When a solid blue-chip stock suddenly pulls back, the knee-jerk reaction for most investors is to jump in and buy the dip. Singapore banks are well known for their strong capital ratios, resilient ROEs, and dominant regional franchises, so buying the dip feels like a no-brainer.
However, I base my decisions on market data and statistical evidence rather than pure emotion. As an OCBC shareholder, that’s why I'm doing nothing for now.
Looking at the OCBC chart, the stock has been trading above its +2 standard deviation band since July—a clear sign that it's overextended from its historical mean. On top of that, my quantitative model flagged early distribution alerts back in July and August. With the stock still well above its mean, there's simply no statistical reason to buy right now.
From a fundamental standpoint, valuing a bank on a single peak quarter makes it easy to justify an inflated stock price. A true value investor looks across the full business cycle.
Over the past five years, OCBC’s Return on Equity (ROE) has averaged roughly 12.14%—smoothing out both the ultra-low rates of 2021 and the rate-hike windfall of 2023.
Applying a standard 8.5% cost of equity and a 3% long-term growth rate, that normalized 12.14% ROE supports a fair Price-to-Book (P/B) multiple of around 1.66x. Against its current book value of S$13.73, this translates to a normalized fair value of about S$22.80 per share (around the -1SD in the chart).
However, a disciplined investor always demands a margin of safety against potential headwinds—like aggressive rate cuts or spiking regional credit losses. Requiring a modest 10% to 15% discount to fair value (or a targeted P/B of 1.4x to 1.5x) places a prudent entry target in the S$19.40 to S$20.50 range (around the -2SD in the chart).
No comments:
Post a Comment